Related Experiment Video
Updated: Jul 4, 2026

Live-imaging of the Drosophila Pupal Eye
Published on: January 12, 2015
Relationship of Pax6 activity levels to the extent of eye development in the mouse, Mus musculus
Jack Favor1, Christian Johannes Gloeckner, Angelika Neuhäuser-Klaus
1Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, D-85764 Neuherberg, Germany. favor@helmholtz-muenchen.de
Abstract:
In this study we extend the mouse Pax6 mutant allelic series to include a homozygous and hemizygous viable hypomorph allele. The Pax6(132-14Neu) allele is a Phe272Ile missense mutation within the third helix of the homeodomain. The mutant Pax6 homeodomain shows greatly reduced binding activity to the P3 DNA binding target. Glucagon-promoter activation by the entire mutant Pax6 product of a reporter gene driven by the G1 paired and homeodomain DNA binding target was slightly increased. We constructed mutant Pax6 genotypes such that Pax6 activity ranged between 100 and 0% and show that the extent of eye development is progressively reduced as Pax6 activity decreased. Two apparent thresholds identify three groups in which the extent of eye development abruptly shifted from complete eye at the highest levels of Pax6 to a rudimentary eye at intermediate levels of Pax6 to very early termination of eye development at the lowest levels of Pax6. Of the two Pax6-positive regions that participate in eye development, the surface ectoderm, which develops into the lens vesicle and the cornea, is more sensitive to reduced levels of Pax6 activity than the optic vesicle, which develops into the inner and outer retinal layers.
Insights
This study introduces a new mouse Pax6 hypomorph allele, revealing that reduced Pax6 activity progressively impairs eye development. Specific thresholds in Pax6 levels dictate shifts from complete to rudimentary or terminated eye formation.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Pax6 is a crucial transcription factor for eye development.
- Understanding Pax6's dosage sensitivity is vital for developmental studies.
Purpose of the Study:
- To investigate the impact of varying Pax6 activity levels on mouse eye development.
- To characterize a novel hypomorphic Pax6 allele, Pax6(132-14Neu).
Main Methods:
- Generated and analyzed mice with a range of Pax6 activity levels (0-100%).
- Utilized a missense mutation (Phe272Ile) in the Pax6 homeodomain.
- Assessed DNA binding activity and reporter gene activation.
Main Results:
- Reduced Pax6 activity leads to a progressive decrease in eye development.
- Two critical thresholds of Pax6 activity were identified, defining distinct eye development outcomes.
- The surface ectoderm is more sensitive to decreased Pax6 levels than the optic vesicle.
Conclusions:
- Pax6 exhibits critical dosage-dependent roles in eye morphogenesis.
- The Pax6(132-14Neu) allele provides a tool to study these dose-dependent effects.
- Differential sensitivity of ocular tissues to Pax6 levels highlights regulatory complexity.
